John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,000 shares at $38.00 ($38K) on 2015-01-29, disclosed to the SEC on 2015-02-02.
Scheduled sale ($38k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |